TrialCompass TCL
Back to results
RecruitingPriority 4 · Lower priorityNCT02840747

Tissue Repository: CTCL Collection Protocol

ClinicalTrials.gov

Plain-language summary

This trial is evaluating a new treatment as a treatment for people newly diagnosed with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. It is available at 1 US location.

Who can join (key eligibility)

  • Age 18 Years or older
  • Newly diagnosed, not yet treated

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Drugs / treatments
Treatment length
Ask the trial team for details
Visit frequency
Ask the trial team for details
TrialCompass — Clinical Trial Summary

Tissue Repository: CTCL Collection Protocol

NCT02840747

Phase: | Status: Recruiting | Priority: Lower

Plain-language summary

This trial is evaluating a new treatment as a treatment for people newly diagnosed with cutaneous T-cell lymphoma (skin lymphoma). The study measures how well this treatment works and monitors for side effects. It is available at 1 US location.

Who can join

  • Age 18 Years or older
  • Newly diagnosed, not yet treated

What's being tested

Drugs / treatments:

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, blind

Enrollment target: 400 patients

Primary endpoint: Number of biological specimen collections

Ages: 18 Years to —

Start date: 2016-07 | Est. completion: 2026-10

Locations

1 US sites · 1 total

New York

Contact

Larisa J. Geskin, MD | ljg2145@cumc.columbia.edu

Sponsor: Columbia University (OTHER)

Tags

CTCL · Newly diagnosed · Relapsed/Refractory

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT02840747

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.